Clinical Trial Update: A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety, efficacy, and tolerability of oral DFD-29 capsules for papulopustular rosacea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papulopustular Rosacea

Drugs mentioned

• DFD-29 capsules (DFD-29)

Snippet

Sponsor: Journey Medical Corporation | Conditions: Papulopustular Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2024-12-03